Trial Profile
Therapeutic Phase IIa Study of ISR-048 in Patients with Confirmed Genital Herpes Simplex Virus Infection
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 29 Mar 2018
Price :
$35
*
At a glance
- Drugs Triptorelin (Primary)
- Indications Herpes genitalis; Herpes simplex virus infections; Herpes simplex virus type 2 infections
- Focus Therapeutic Use
- 29 Mar 2018 New trial record